SELENOP and colorectal cancer: In 2010, C. Méplan et al. reported that people with the nonGG genotype of the SEPP1 (rs7579) polymorphism had a 1.43 times higher risk of developing colorectal cancer compared to patients with the GG genotype (95% Cl 1.00–2.05, p-value 0.048).